PENTICTON, BC, /CNW/ – XCO Tech Inc. (XCO) today announced it is receiving advisory services and funding of up to $1M from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)… Read More
Vancouver, BC – Qu Biologics Inc., a clinical stage biotechnology company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to… Read More
Industry innovator developing products for improving immune system competence, announces completion of clinical study and filing of US & international patent applications. VANCOUVER, BC, CNW – ImmunoFlex™, a life sciences… Read More
PENTICTON, BC /CNW/ – XCO Tech Inc. (XCO) today announced it is receiving advisory services and funding of up to $1M from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) over… Read More
VANCOUVER, BC– NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, today announced… Read More
